Search for: "MERCK & CO., INC. " Results 201 - 220 of 669
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2016, 9:16 am by Dennis Crouch
The Merck petition is focused on pre-AIA patents. [read post]
12 Jun 2017, 3:18 pm by escherer@lawbc.com
    This year's winners and technologies are: Merck & Co., Inc. in Greener Synthetic Pathways - Letermovir: A Case Study in State-of-the-Art Approaches to Sustainable Commercial Manufacturing Processes in the Pharmaceutical Industry Merck’s approach was to design an efficient synthesis as early as possible in the drug Letermovir’s process development. [read post]
14 Jun 2019, 7:33 am by lbergeson@lawbc.com
Congratulated by EPA Assistant Administrator Alexandra Dapolito Dunn, the 2019 awardees included: Academic Award -- Professor Sanjoy Banerjee, The City University of New York – Energy Institute, Rechargeable Alkaline Zn-MnO2 Batteries for Grid Storage Applications;   Small Business Award -- Kalion, Inc., Microbially Produced High-Purity Glucaric Acid for Diverse Uses;   Greener Synthetic Pathways Award -- Merck & Co., Innovating for a Greener… [read post]
27 Apr 2010, 7:33 am by N. Peter Rasmussen
In securities fraud cases, held the Court, facts showing scienter are among those that constitute the violation (Merck & Co., Inc. v. [read post]
27 Mar 2015, 5:31 am by Lawrence B. Ebert
”[3] Also, in a January 21 letter to the House Judiciary Committee, a host of 250 companies, start-ups, and known innovators — including Qualcomm Inc., Merck & Co., and Monsanto Co. [read post]
16 Jun 2017, 9:44 am by rengler@lawbc.com
    This year's winners and technologies are: Merck & Co., Inc. in Greener Synthetic Pathways -- Letermovir: A Case Study in State-of-the-Art Approaches to Sustainable Commercial Manufacturing Processes in the Pharmaceutical Industry; Amgen Inc. and Bachem in Greener Reaction Conditions -- Green Process for Commercial Manufacture of Etelcalcetide Enabled by Improved Technology for Solid Phase Peptide Synthesis;  The Dow Chemical… [read post]
2 Nov 2009, 9:57 am
FTC, Canada Competition Bureau Approve Schering-Plough's Acquisition of MerckThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Schering-Plough Corporation can proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
27 Jun 2011, 9:40 pm by Patent Docs
The panel consisted of patent counsel from both brand and generic industries, including Mark Bowditch (Sandoz, Inc.), Edward Murray (Merck & Co., Inc.), and Bart Newland... [read post]
11 Oct 2018, 12:57 am by Eszter Szakács
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
25 Jan 2012, 2:27 pm by Michelle Yeary
Merck & Co., Inc., No. 10-4196-cv, slip op. (2d Cir. [read post]